Spots Global Cancer Trial Database for comparative genomic hybridization
Every month we try and update this database with for comparative genomic hybridization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
Oral HPV Infection in Young Men | NCT00897273 | Head and Neck C... Infection Precancerous Co... | comparative gen... gene expression... study of socioe... evaluation of c... study of high r... | 18 Years - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Research Study in Patients With Advanced Ovarian Epithelial Cancer | NCT00053235 | Ovarian Serous ... Ovarian Serous ... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... | Comparative Gen... Laboratory Biom... Polymerase Chai... | - | GOG Foundation | |
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma | NCT00049010 | Melanoma (Skin) | comparative gen... cytogenetic ana... fluorescence in... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | NCT00967954 | Prostate Cancer | antiandrogen th... releasing hormo... DNA analysis RNA analysis comparative gen... gene expression... laboratory biom... diffusion-weigh... magnetic resona... | - | National Cancer Institute (NCI) | |
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer | NCT00898313 | Lung Cancer | comparative gen... gene expression... proteomic profi... biologic sample... nasal brushing Blood draw Urine collectio... sputum sample fluorescence br... fine needle asp... thoracentesis | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer | NCT00070278 | Breast Cancer | cyclophosphamid... epirubicin hydr... gemcitabine hyd... paclitaxel comparative gen... microarray anal... mutation analys... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer | NCT00898313 | Lung Cancer | comparative gen... gene expression... proteomic profi... biologic sample... nasal brushing Blood draw Urine collectio... sputum sample fluorescence br... fine needle asp... thoracentesis | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Biomarkers in Young Patients With Neuroblastoma | NCT01169376 | Neuroblastoma | DNA analysis DNA methylation... RNA analysis comparative gen... mutation analys... polymorphism an... | - 30 Years | Children's Oncology Group | |
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil | NCT00897091 | Breast Cancer | comparative gen... microarray anal... reverse transcr... diagnostic labo... | 18 Years - | SWOG Cancer Research Network | |
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy | NCT00471653 | Brain and Centr... Thrombocytopeni... | temozolomide comparative gen... polymorphism an... laboratory biom... pharmacological... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants | NCT00433485 | Neoplastic Synd... Non-melanomatou... | sirolimus comparative gen... gene expression... microarray anal... protein express... proteomic profi... laboratory biom... mass spectromet... biopsy | 18 Years - 120 Years | Yale University | |
Studying Genes for Barrett's Esophagus in Brothers and Sisters | NCT00516347 | Esophageal Canc... Precancerous Co... | comparative gen... genetic linkage... laboratory biom... questionnaire a... study of high r... | - | National Cancer Institute (NCI) | |
Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) |